9 completed, 1 recruiting, 1 terminated, 1 unknown. 6 Phase 3, 2 Phase 2, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 3, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 2 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Orchiectomy: new trials by email Literature Review of Orchiectomy trials Research Report on Orchiectomy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exogenous Sex Hormones and PONV Orchiectomy, Hysterectomy, Augmentation mammoplasty - Postoperative Nausea and Vomiting, Sex Hormone | Completed | Riverside University Health System Medical Center | 7348 | 2025-02-04 | 2025-02-21 | |
| Malignant Testicular Tumors in Children: A Single Institution's 12-year Experience Orchiectomy - Overall Survival Rates | Completed | Chang Gung Memorial Hospital | 42 | 2020-12-01 | 2021-04-01 | |
| Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer Abiraterone, Bicalutamide, Degarelix - Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma | Phase 3 | Recruiting | SWOG Cancer Research Network | 1273 | 2018-09-24 | 2026-10-08 |
| LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer enzalutamide, bicalutamide, orchiectomy - Adenocarcinoma of the Prostate, Recurrent Prostate Cancer | Phase 2 | Completed | Barbara Ann Karmanos Cancer Institute | 71 | 2014-05-01 | 2023-05-10 |
| MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism Triptorelin, Orchiectomy - Prostate Cancer, Metabolic Syndrome | Phase 4 | Completed | Herlev Hospital | 31 | 2014-04-01 | 2015-10-28 |
| Subcapsular Orchiectomy in Men With Klinefelter Syndrome Orchiectomy - Klinefelter Syndrome | Not applicable | Completed | Odense University Hospital | 14 | 2010-08-01 | 2016-10-04 |
| Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer antiandrogen therapy, docetaxel, goserelin acetate - Prostate Cancer | Phase 3 | Completed | UNICANCER | 385 | 2004-10-18 | 2021-02-21 |
| Androgen Deprivation Therapy in Treating Patients With Prostate Cancer antiandrogen therapy, releasing hormone agonist therapy, orchiectomy - Prostate Cancer | Phase 3 | Unknown | Peter MacCallum Cancer Centre, Australia | 2000 | 2004-10-01 | 2013-08-07 |
| Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases Doxorubicin hydrochloride, Goserelin acetate, Leuprolide acetate - Metastatic Cancer, Prostate Cancer | Phase 2 | Completed | M.D. Anderson Cancer Center | 80 | 2004-07-01 | 2016-11-10 |
| Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer bicalutamide, goserelin acetate, orchiectomy - Prostate Cancer | Phase 3 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 110 | 2001-01-01 | 2012-09-24 |
| Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer flutamide, goserelin acetate, leuprolide acetate - Prostate Cancer | Phase 3 | Completed | Eastern Cooperative Oncology Group | 1996-10-01 | 2010-11-09 | |
| Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer bicalutamide, buserelin, flutamide - Prostate Cancer | Phase 3 | Completed | NCIC Clinical Trials Group | 361 | 1995-02-08 | 2020-04-03 |
Prostatic Neoplasms (9) · Fatty Liver (1) · Hypogonadism (1) · Klinefelter Syndrome (1) · Metabolic Syndrome (1) · Neoplasm Metastasis (1) · Postoperative Nausea and Vomiting (1) · Testicular Neoplasms (1)
Barbara Ann Karmanos Cancer Institute (1) · Chang Gung Memorial Hospital (1) · Eastern Cooperative Oncology Group (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Herlev Hospital (1) · M.D. Anderson Cancer Center (1) · NCIC Clinical Trials Group (1) · Odense University Hospital (1) · Peter MacCallum Cancer Centre, Australia (1) · Riverside University Health System Medical Center (1) · SWOG Cancer Research Network (1) · UNICANCER (1)
United States (5) · Denmark (2) · Australia (1) · Canada (1) · Chile (1) · Colombia (1) · France (1) · Germany (1) · Mexico (1) · New Zealand (1) · Switzerland (1) · Taiwan (1)
A. O. Sartor, MD (1) · Brian Chapin (1) · Elisabeth Heath, M.D. (1) · George Wilding, MD (1) · Gerald H.J. Mickisch, MD (1) · Gillian M. Duchesne, MD, FRCR (1) · Gwenaelle Gravis, MD (1) · Malcolm D. Mason, MD (1) · Nancy A. Dawson, MD (1) · Padraig R. Warde, MB, MRCPI, FRCPC (1) · Patricia Lillis-Hearne, MD (1) · Richard R. Whittington, MD (1) · Shi-Ming Tu, MD (1) · Srinivasan Vijayakumar, MD (1)
PMID 22056152, PMID 22747660, PMID 23306100, PMID 24210084, PMID 25592642, PMID 25691677, PMID 26014295, PMID 26254174, PMID 27155740, PMID 28760403, PMID 33496795, PMID 41628415
P30CA022453 (1), U10CA045809 (1), U10CA180888 (1)